Tetrahydrothienopyridine derivatives as novel GPIIb/IIIa antagonists

Tetrahydrothienopyridine derivatives as novel GPIIb/IIIa antagonists Cyclic guanidines. 14. Imidazo[1,2-a]thienopyrimidin-2-one derivatives as blood platelet aggregation inhibitors Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp) Synthesis of a piperidinomethylthiophene derivative as H2-antagonist with inhibitory activity against Helicobacter pylori Cyclic guanidines. 17. Novel (N-substituted amino)imidazo[2,1-b]quinazolin-2-ones: water-soluble platelet aggregation inhibitors Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (.+-.)-(5Z)-7-[3-endo[(phenylsulfonyl)amino]bicyclo[2.2.1]hept-2-exo-yl]heptenoic acid Docking based design of diastereoisomeric MTCA as GPIIb/IIIa receptor inhibitor Several non-salt and solid thienopyridine derivatives as oral P2Y12 receptor inhibitors with good stability Tetrafibricin: A nonpeptidic fibrinogen receptor inhibitor from Streptomyces neyagawaensis (I) its GPIIB/IIIA blockage on solid phase binding assay